📱Supersapiens: Get real-time biometric insights

15,000+ users | Led by industry veterans in healthcare, sports, and finance   Milestone reached: Supersapiens ~/AAQRxQA~/RgRnYucSP0SuaHR0cHM6Ly9yZXB1YmxpYy5jb20vc3VwZXJzYXBpZW5zP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PXN1cGVyc2FwaWVuc19hbGwmdXRtX3Rlcm09c3VwZXJzYXBpZW5zVwNzcGNCCmV8E2KAZZOKIc1SG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~   ~/AAQRxQA~/RgRnYucSP0SuaHR0cHM6Ly9yZXB1YmxpYy5jb20vc3VwZXJzYXBpZW5zP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PXN1cGVyc2FwaWVuc19hbGwmdXRtX3Rlcm09c3VwZXJzYXBpZW5zVwNzcGNCCmV8E2KAZZOKIc1SG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ ~/AAQRxQA~/RgRnYucSP0SuaHR0cHM6Ly9yZXB1YmxpYy5jb20vc3VwZXJzYXBpZW5zP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PXN1cGVyc2FwaWVuc19hbGwmdXRtX3Rlcm09c3VwZXJzYXBpZW5zVwNzcGNCCmV8E2KAZZOKIc1SG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ Min. investment $250 Supersapiens: Unlocking human health & performance Supersapiens is a real-time biometric insights platform with a focus on diabetes management, offering a glucose monitoring platform to optimize health and performance. With a wealth of data points and partnerships with renowned sports organizations, Supersapiens provides continuous glucose visibility, daily insights, a glucose score, and a desktop portal for enhanced diabetes management. Led by industry veterans and founders in healthcare, sports, and finance, Supersapiens employs a SaaS subscription model. The company has demonstrated impressive traction with $2 million in 2022 EU revenue and 15,000+ users. Highlights: - Q1 2024: Aims to target the US market with a focus on diabetes management - Glucose monitoring platform for optimizing health & performance - Insights for metabolic health via glucose, first launched in Europe - Partnered with a market leader to enhance US diabetes management - One of the world's largest glucose dataset (non-diabetic): 1B+ data points - Trusted by Olympians, F1, UEFA, NBA, PGA, NFL, NHL, MLB, TDF, Ironman - Seamlessly integrates with Apple Health, Oura, Garmin, Wahoo, and others ~/AAQRxQA~/RgRnYucSP0SuaHR0cHM6Ly9yZXB1YmxpYy5jb20vc3VwZXJzYXBpZW5zP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PXN1cGVyc2FwaWVuc19hbGwmdXRtX3Rlcm09c3VwZXJzYXBpZW5zVwNzcGNCCmV8E2KAZZOKIc1SG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~ [View Supersapiens on Republic](~/AAQRxQA~/RgRnYucSP0SuaHR0cHM6Ly9yZXB1YmxpYy5jb20vc3VwZXJzYXBpZW5zP3V0bV9zb3VyY2U9cmVwdWJsaWMuY29tJnV0bV9tZWRpdW09ZW1haWwmdXRtX2NhbXBhaWduPW5ld3NsZXR0ZXJfbWFpbGVyLndlZWtseV9uZXdzbGV0dGVyJnV0bV9jb250ZW50PXN1cGVyc2FwaWVuc19hbGwmdXRtX3Rlcm09c3VwZXJzYXBpZW5zVwNzcGNCCmV8E2KAZZOKIc1SG3RyaXN0cmFtYmFsZHdpbjkwQGdtYWlsLmNvbVgEAAABzg~~)     Highlights are derived, and based entirely upon the Issuer’s representations. Prior results do not guarantee future success. Images provided by the issuer. Investments in private companies are particularly risky and may result in total loss of invested capital. This email was sent by Republic. Crowdfunding investments can result in total loss, and may be impossible to resell. Read about risks. Republic Core LLC ("Core") provides technology and support services to OpenDeal Inc. and its affiliates (collectively, the "Republic Ecosystem"). Republic Note holders and as well as users of the site and services maintained by the Republic Ecosystem, regardless of and their activities on or relating to the Republic Ecosystem, are subject to the applicable terms of service, in their entirety. Core cannot give investment advice, analysis or recommendations with respect to any securities, and is not a registered broker-dealer, funding portal or investment adviser. Securities offerings displayed by Core may be facilitated by its affiliates in the Republic Ecosystem, OpenDeal Portal LLC d/b/a Republic, or OpenDeal Broker LLC d/b/a The CapitalR, Republic Capital Adviser LLC, Republic Deal Room Advisor LLC, Fig Publishing, Inc. or by a third-party issuer. This email is intended only for accredited investors with a pre-existing relationship with the Republic Ecosystem. Please notify the sender immediately if you have received this email by mistake, then delete it. Private investments are risky and illiquid, never invest more than you can afford to lose, consult with your trusted advisors and do your own diligence before investing. This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed; they do not constitute legal or investment advice. Please notify the sender immediately if you have received this e-mail by mistake, then delete it. No longer interested in new offering launch emails? Adjust your [notification settings](~/AAQRxQA~/RgRnYucSP0QraHR0cHM6Ly9yZXB1YmxpYy5jb20vc2V0dGluZ3Mvbm90aWZpY2F0aW9uc1cDc3BjQgplfBNigGWTiiHNUht0cmlzdHJhbWJhbGR3aW45MEBnbWFpbC5jb21YBAAAAc4~). [Unsubscribe from all emails](~/AAQRxQA~/RgRnYucSP4TIAWh0dHBzOi8vMDUuZW1haWxpbmJvdW5kcHJvY2Vzc2luZy5jb20vZW5jX3VzZXIvdW5zdWJzY3JpYmU_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~) 149 E 23rd St #2001, New York, NY 10010